Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

QTTBQTTB
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Q32 BIO INC

No. Goldman Sachs exited its QTTB (Q32 Bio) position in Q3 2025. Its Q2 2025 13F listed 63,539 shares worth $94,673. Goldman Sachs first reported QTTB in Q2 2024 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$214,359

Total Shares Change

-11,942

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.94
0
2025-Q2
Increased
63,539
+43.2%
$94,6730.0%$1.45
20
2025-Q1
Increased
44,373
+140.9%
$73,2160.0%$1.71
23
2024-Q4
Increased
18,420
+48.1%
$63,3650.0%$3.11
20
2024-Q3
Increased
12,434
+4.1%
$554,8050.0%$46.00
25
2024-Q2
New
11,942
-
$214,3590.0%$17.95
35

Other major holders of QTTB: Carlyle Group Inc., RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used